EATG » News

HEALTH CIVIL SOCIETY CALLS UPON MEMBER STATES TO SUPPORT EUROPEAN PARLIAMENT’S STRONG STAND ON HEALTH WITHIN THE EU BUDGET 2021-2027

On 1 April 2019, health civil society has published a statement calling on the Council and its Working Party on Structural Measures, responsible for the European Social Fund Plus (ESF+) file, to uphold…

STEP-UP 2013-2017 impact assessment report is out

Today, the European AIDS Treatment Group is publishing a report that aims to assess the impact the STEP-UP Training Academy programme had to its participants as well as to their…

Ageing with HIV Taskforce Meeting: Operationalising Ageing with HIV project R&D Outcomes and Identified Research

The European AIDS Treatment Group (EATG), held a meeting titled ‘Taskforce meeting: Operationalising Ageing with HIV project R&D Outcomes and identified research' in Frankfurt, Germany, on 21 of March 2019.…

Civil society welcomes European Parliament push for a more ambitious EU health budget in 2021-2027

The EU Civil Society Forum on HIV/AIDS, tuberculosis (TB) and viral hepatitis and the Civil Society Forum on Drugs are encouraged to note that the European Parliament has improved the Commission…

A reflection paper dangerously lacking reflection on reaching the agreed target of HIV, viral hepatitis and TB elimination by 2030

Today, the EU Civil Society Forum on HIV/AIDS, tuberculosis and viral hepatitis issues a statement in response to European Commission's reflection paper Towards a Sustainable Europe by 2030. The paper…

The EATG endorses Life4me+ organisation and app

The European AIDS Treatment Group and Life4me.plus to fight AIDS, Hepatitis C and Tuberculosis have agreed to a mutual endorsement as partners.   Life4me+ is a community-based non-profit organisation, which…

The European AIDS Treatment Group names new Executive Director

The European AIDS Treatment Group (EATG) is delighted to introduce our new Executive Director, Pieter Vanholder. Pieter has a background in human rights and law and over a decade of…

#EU4Health: An overarching EU SDG implementation strategy is the only viable scenario

The European AIDS Treatment Group has co-signed a reaction letter to the European Commission’s Reflection Paper: Towards a Sustainable Europe by 2030, together with organisations that have endorsed the #EU4Health…

The EATG urges the Romanian government to adopt and implement the 2019-2021 HIV/AIDS National Strategic Plan

BRUSSELS - Today the European AIDS Treatment Group addresses a letter to the Romanian government in view of the new HIV/AIDS National Strategic Plan. In support of the demands and…

ОТЧЕТ ПО ДОСТУПУ К УСЛУГАМ, ОКАЗЫВАЕМЫМ ПРИ ВИРУСНОМ ГЕПАТИТЕ С, В МЕСТАХ ЛИШЕНИЯ СВОБОДЫ В ЕВРОПЕ ТЕПЕРЬ ЕСТЬ И НА РУССКОМ ЯЗЫКЕ – The report on access to HCV-related services in prison settings in Europe is now available in Russian

Отчет по доступу к услугам, оказываемым при вирусном гепатите С, в местах лишения свободы в Европе теперь есть и на русском языке. Несколько месяцев назад EATG опубликовала этот отчет и…

HepHIV2019: Meeting on implementing HIV, HBV and HCV testing guidance in the real world

In the frame of the HepHIV2019 conference taking place next week in Bucharest (28-30 January), the European AIDS Treatment Group and EuroTEST (formerly HIV in Europe) are co-hosting a multi-stakeholder breakfast…

Call for applications: Continuous Patient Education (CoPE) new call opens

We are pleased to announce that a call for applications for CoPE is now open. Please find below detailed information on how to apply for this grant. The submission deadline is 11…

The EATG publishes its position paper on sex work policy

Today, on the occasion of the International Day to End Violence Against Sex Workers, the European AIDS Treatment Group publishes its stand on the sex work policy debate and approaches…

Vieillir avec le VIH: Brussels-based organisations met to discuss about ageing with HIV

This week the European AIDS Treatment Group participated in a meeting on “Ageing with HIV: What challenges? What ways forward?”, organised by two francophone organisations based in Brussels that work…

The European AIDS Treatment Group supports the petition towards the next Global Fund Replenishment Conference

Ahead of the next conference to replenish the Global Fund in October 2019 in France, AIDES -together with collaborating organisations (Action Santé Mondiale / Global Health Advocates, Coalition PLUS, Équilibres & Populations, Médecins du…

Reporting from the 2nd Hep-C Community Summit (Lisbon, 18 September 2018)

The Hep-C Community Summit, organised by Correlation European Harm Reduction Network, has brought together people from the affected communities, advocates, researchers, healthcare providers, harm reduction practitioners, and policymakers to discuss…

EHVA: European HIV advocates discuss about new clinical study aiming to evaluate experimental strategies for the control of HIV infection

On Thursday, 15th of November, the European AIDS Treatment Group hosted a meeting with members of HIV organisations from six European countries to discuss the launch of the study EHVA…

HIV Outcomes: Online Compendium of Good Practices for the long-term health of people living with HIV launched

BRUSSELS: Today, HIV Outcomes launched an Online Compendium of Good Practices for securing the long-term health and well-being of people living with HIV.   Although people with HIV can now anticipate…

EmERGE: Community Meeting for the Last Phase of the Project (Madrid – November 7 2018)

The EmERGE project (about developing a mHealth platform for self-management of HIV and reducing face-to-face consultations), funded by the European Commission, has started its last 18 months. The European AIDS…

14 Patient Organisations Call for Meaningful Involvement in European Cooperation on Health Technology Assessment (HTA)

Today, 14 European patient organisations & federations have launched a statement calling on European institutions to adopt appropriate measures to fully incorporate meaningful involvement of patients in EU cooperation on…

Corporate reputation of pharma in 2018 – the global patient perspective

Corporate reputation of pharma in 2018: What 1, 500 patient groups from around the world think of 46 pharma companies in 2018 Read the full press release here.  

Novel antibody may suppress HIV for up to four months

In rare cases, immune system fails despite HIV suppression

Thousands feared at risk after Mexico reforms HIV+ regime

MEXICO CITY - Thousands of Mexicans living with HIV or at risk of infection could be left without life-saving services after the government changed the way it funds treatment, according…

CROI 2019: Young people born with HIV more likely to have “mild” verbal memory test deficits if they have ever had an AIDS-defining condition

No significant difference between others born with HIV and matched HIV-negative peers A study presented at this year’s Conference on Retroviruses and Opportunistic Infections (CROI 2019) in Seattle found that young…

How the hepatitis B virus establishes persistent infection

New research sheds light on how a hepatitis B viral protein stimulates the expansion of immune cells that impair antiviral responses, according to a study published April 18 in the…

Treatment switch for hep B patients with renal, bone risk

SAN DIEGO — Patients with hepatitis B at particular risk for bone and renal harm from tenofovir disoproxil fumarate (TDF; Viread, Gilead Sciences) might benefit from a switch to tenofovir alafenamide…

US and Malawian partners implement malaria vaccine for children in Africa

Aidspan publishes new issue of ‘Global Fund Observer’

Aidspan: Global Fund Observer Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 354 of the ‘Global Fund Observer.’ The newsletter includes pieces…

Letter to FDA regarding application for Descovy as PrEP

April 16, 2019 – Treatment Action Group (TAG) and PrEP4All sent a letter to Dr. Debra Birnkrant of the US Food and Drug Administration (FDA), outlining and expressing their serious…

Promising malaria vaccine to be tested in first large field trial

The vaccine can confer up to 100% protection and will be tested in 2,100 people on the west African island of Bioko. A malaria vaccine that can provide up to…

Previous HAV vaccination does not reliably protect some patients with HIV

Study findings suggest that previous vaccination against hepatitis A virus infection does not reliably protect some people with HIV. Researchers found that more than half of people with HIV who…

BHIVA 2019: Older black HIV-positive women have more mental distress than other women with HIV, but get less help for it

Older African women are also better educated than others, but more likely to be poor A study looking at women aged over 45 living with HIV in the UK has…

“Dialogue” highlighted as way forward at closure of WHO Fair Pricing Forum

WHO said that it will launch a public online consultation involving governments, industry and civil society to try to come up with a broad consensus on what actually constitutes a…

CDISC, C-Path develop Therapeutic Area Standard to foster more efficient and meaningful research for HIV

AUSTIN, TX and TUCSON, AZ – 16 Apr 2019 – CDISC and the Critical Path Institute (C-Path) are pleased to announce the release of a global Therapeutic Area Standard that specifies how…

Study examines HCV retreatment regimen in patients with previous virologic failure

Although direct-acting antivirals (DAAs) are an effective therapy for patients with HCV, those who experience virologic failure with prior treatment remain a difficult-to-cure population. Glecaprevir/pibrentasvir (G/P) has demonstrated efficacy and…

Weight gain with new antiretrovirals: Its complicated

South Africa’s next big shift in our antiretroviral programme is to replace efavirenz with a newish drug called dolutegravir. The last big change was from stavudine (d4T) to tenofovir, and…

Dual therapy with rilpivirine and boosted darunavir is effective in PLWHIV

Rilpivirine plus boosted-darunavir (RPV + bDRV) dual therapy may be effective and safe in patients with advanced HIV infection and previous virologic failure according to a study recently published in BMC…

PrEP officially launched in Hanoi

Pre-Exposure Prophylaxis (PrEP) service for HIV prevention was officially launched in Hanoi on April 16. PrEP allows people who do not have HIV but are at substantial risk of infection…

TB LAM testing briefs

Two important tools for activists to use with donors and national TB programs in advocating for increased scale-up of the inexpensive, urine TB LAM test - an essential diagnostic test…